An open invitation to the cancer immunology community. by Srivastava, P, Cerundolo, V, Knuth, A, Allison, J

Identification of NY-ESO-1 peptide analogues capable of improved stimulation of tumor-reactive CTL. by Chen, J, Dunbar, P, Gileadi, U, Jäger, E, Gnjatic, S, Nagata, Y, Stockert, E, Panicali, D, Chen, Y, Knuth, A, Old, L, Cerundolo, V

Strategy for monitoring T cell responses to NY-ESO-1 in patients with any HLA class I allele. by Gnjatic, S, Nagata, Y, Jager, E, Stockert, E, Shankara, S, Roberts, B, Mazzara, G, Lee, S, Dunbar, P, Dupont, B, Cerundolo, V, Ritter, G, Chen, Y, Knuth, A, Old, L

Targeting mutated plus germline epitopes confers pre-clinical efficacy of an instantly formulated cancer nano-vaccine by Mohsen, M, Vogel, M, Riether, C, Muller, J, Salatino, S, Ternette, N, Gomes, A, Cabral-Miranda, G, El-Turabi, A, Ruedl, C, Kundig, T, Dermime, S, Knuth, A, Speiser, D, Bachmann, M

NY-ESO-1 protein glycosylated by yeast induces enhanced immune responses. by Wadle, A, Mischo, A, Strahl, S, Nishikawa, H, Held, G, Neumann, F, Wullner, B, Fischer, E, Kleber, S, Karbach, J, Jager, E, Shiku, H, Odunsi, K, Shrikant, P, Knuth, A, Cerundolo, V, Renner, C

Monitoring CD8 T cell responses to NY-ESO-1: correlation of humoral and cellular immune responses. by Jäger, E, Nagata, Y, Gnjatic, S, Wada, H, Stockert, E, Karbach, J, Dunbar, P, Lee, S, Jungbluth, A, Jäger, D, Arand, M, Ritter, G, Cerundolo, V, Dupont, B, Chen, Y, Old, L, Knuth, A

Rational development of high-affinity T-cell receptor-like antibodies (vol 106, pg 5784, 2009) by Stewart-Jones, G, Wadle, A, Hombach, A, Shenderov, E, Held, G, Fischer, E, Kleber, S, Nuber, N, Stenner-Liewen, F, Bauer, S, McMichael, A, Knuth, A, Abken, H, Hombach, A, Cerundolo, V, Jones, E, Renner, C

Rational development of high-affinity T-cell receptor-like antibodies. by Stewart-Jones, G, Wadle, A, Hombach, A, Shenderov, E, Held, G, Fischer, E, Kleber, S, Nuber, N, Stenner-Liewen, F, Bauer, S, McMichael, A, Knuth, A, Abken, H, Hombach, A, Cerundolo, V, Jones, E, Renner, C

Rational development of high-affinity T-cell receptor-like antibodies (Proceedings of the National Academy of Sciences of the United States of America (2009) 106, 14, (5784-5788) D... by Stewart-Jones, G, Wadle, A, Hombach, A, Shenderov, E, Held, G, Fischer, E, Kleber, S, Nuber, N, Stenner-Liewen, F, Bauer, S, McMichael, A, Knuth, A, Abken, H, Hombach, A, Cerundolo, V, Jones, E, Renner, C

Vaccination with nanoparticles combined with micro-adjuvants protects against cancer by Mohsen, MO, Heath, MD, Cabral-Miranda, G, Lipp, C, Zeltins, A, Sande, M, Stein, JV, Riether, C, Roesti, E, Zha, L, Engroff, P, El-Turabi, A, Kundig, TM, Vogel, M, Skinner, MA, Speiser, DE, Knuth, A, Kramer, MF, Bachmann, MF

Memory and effector CD8 T-cell responses after nanoparticle vaccination of melanoma patients. by Speiser, D, Schwarz, K, Baumgaertner, P, Manolova, V, Devevre, E, Sterry, W, Walden, P, Zippelius, A, Conzett, K, Senti, G, Voelter, V, Cerottini, J, Guggisberg, D, Willers, J, Geldhof, C, Romero, P, Kündig, T, Knuth, A, Dummer, R, Trefzer, U, Bachmann, M